Hamilton Capital Partners (Canada)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.8M Buy
172,604
+428
+0.2% +$99.7K 1.27% 25
2026
Q1
$42.1M Sell
172,176
-24,282
-12% -$5.66M 1.41% 18
2025
Q4
$40.7M Buy
196,458
+11,108
+6% +$2.2M 1.49% 19
2025
Q3
$34.4M Buy
185,350
+17,698
+11% +$3.03M 1.42% 19
2025
Q2
$25.6M Buy
167,652
+25,219
+18% +$3.88M 1.31% 25
2025
Q1
$23.6M Buy
142,433
+14,553
+11% +$2.28M 1.52% 20
2024
Q4
$18.5M Buy
127,880
+11,435
+10% +$1.77M 1.38% 24
2024
Q3
$18.9M Buy
116,445
+10,166
+10% +$1.62M 1.63% 17
2024
Q2
$15.5M Buy
106,279
+8,692
+9% +$1.29M 1.66% 20
2024
Q1
$15.4M Buy
97,587
+52,257
+115% +$8.32M 1.87% 16
2023
Q4
$7.11M Buy
+45,330
New +$6.95M 1.42% 29

Other funds holding JNJ

Hamilton Capital Partners (Canada)'s JNJ Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Johnson & Johnson (JNJ) stake by 0.25% in Q2 2026, buying an estimated $99.7K and bringing the position to 172,604 shares worth $43.8M. The position accounts for 1.27% of the portfolio, ranked #25.

Hamilton Capital Partners (Canada) first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,503 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hamilton Capital Partners (Canada) held 172,604 shares of Johnson & Johnson worth $43.8M as of Q2 2026.
  • Hamilton Capital Partners (Canada) bought 428 Johnson & Johnson shares in Q2 2026, an estimated $99.7K.
  • Johnson & Johnson made up 1.27% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #25 holding.
  • Hamilton Capital Partners (Canada) first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,503 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.